Evaluation of the Role of Creatine Phosphokinase as a Biomarker in Acute Myocardial Infarction Patients

Introduction: The study hypothesized that salivary creatine phosphokinase (CPK) can act as a biomarker in diagnosing acute myocardial infarction (AMI) as an alternative to serum CPK, which is a contributory effort towards noninvasive procedures to detect the disease. Aims and Objectives: The main ai...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Indian Academy of Oral Medicine and Radiology 2017-10, Vol.29 (4), p.263-266
Main Authors: Agrawal, Priyal, Phulambrikar, Tushar, Singh, Siddharth, Gupta, Anjali
Format: Article
Language:English
Subjects:
Acute myocardial infarction
Age groups
Analysis
Anemia
Aurobindo, Sri (1872-1950)
Biochemistry
Biological markers
Biomarkers
Cardiac patients
Cardiovascular disease
Causes of
Creatine
Creatine kinase
Dentistry
Diabetes
Diagnosis
Health aspects
Heart attack
Heart attacks
Medical care
Medicine
Myocardial infarction
Risk factors
Saliva
salivary CPK
Sample size
serum CPK
Statistical analysis
Statistics
Treatment outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: The study hypothesized that salivary creatine phosphokinase (CPK) can act as a biomarker in diagnosing acute myocardial infarction (AMI) as an alternative to serum CPK, which is a contributory effort towards noninvasive procedures to detect the disease. Aims and Objectives: The main aim of our study was to propose the normal range of salivary CPK in patients with AMI, and to explore the relationship between serum and saliva levels of CPK with comparison of salivary CPK as a biomarker between healthy individuals and patients with AMI. Materials and Methods: A case-control study was carried out including 144 participants who were divided in two main groups - 72 normal healthy individuals and 72 with AMI. CPK levels were assayed in serum and unstimulated whole saliva of AMI and controls by International Federation of Clinical Chemistry (IFCC) method. Statistical Analysis: Statistical analysis was performed using unpaired t-test and Pearson correlation coefficient test. Results: The normal proposed range of salivary CPK of patients with AMI was found to range from 11.30 to 184.50 U/L in males and 20.17 to 69.00 U/L in females. The mean salivary and serum CPK was significantly higher in patients with AMI as compared to healthy individuals with P < 0.001. Saliva CPK concentration correlated significantly with serum CPK of AMI and healthy individuals with r = 0.247. Conclusion: Salivary CPK can be used as an alternative to serum CPK in patients with AMI.
ISSN:0972-1363
0975-1572
DOI:10.4103/jiaomr.jiaomr_66_17